Business Context and Reporting Period
This Form 8-K is filed by Sharps Technology, Inc. (trading symbol: STSS) on October 6, 2025. The filing reports the entry into a material definitive agreement and the completion of an asset disposition related to the resolution of ongoing litigation.
Key Financial Metrics
The filing text does not provide specific current period revenue, profit, cash flow, margin, debt, or liquidity figures. However, it references unaudited pro forma condensed consolidated financial information for the six months ended June 30, 2025, and audited statements for the year ended December 31, 2024, which are incorporated by reference in Exhibit 99.1.
Material Changes and Transactions
- Settlement of Litigation: The Company entered into a confidential settlement agreement and release with Barry Berler, Plastomold Industries Ltd, and related entities (collectively "Plasto") to resolve outstanding litigation referenced in the June 30, 2025, Form 10-Q.
- Asset Disposition: As part of the settlement, the Company will transfer specific assets to Plasto Technology Group LLC, including:
- Certain assets via a bill of sale and assignment agreement.
- All rights, title, and interest in the issued and outstanding shares of Safegard Medical Kft, the Company's Hungarian subsidiary.
- Certain patents, registered trademarks, and associated goodwill.
- Release of Claims: Both parties have agreed to unconditionally and irrevocably release each other from all claims alleged in the litigation. The agreement explicitly states that this settlement is not an admission of fault, responsibility, or liability.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, revenue outlook, or management commentary regarding future financial performance. The primary risk addressed is the resolution of the previously disclosed litigation. The Company notes that, aside from Mr. Berler's prior role as a co-founder and former CTO, there are no other material relationships between the Company and the settling parties.
Investor Verification Checklist
- Review Exhibit 10.1 for the full text of the Confidential Settlement Agreement and Release.
- Examine Exhibit 99.1 for the unaudited pro forma financial information to understand the financial impact of the asset transfers.
- Verify the specific assets, patents, and trademarks being transferred to Plasto Technology Group LLC.
- Confirm the status of the Hungarian subsidiary, Safegard Medical Kft, following the transfer of shares.